Octreotide therapy for chylous ascites in a chronic dialysis patient

Pei Hsien Lee, Chun Liang Lin, Ping Chin Lai*, Chih Wei Yang

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

26 Scopus citations

Abstract

Chylous ascites, a rare complication in patients receiving continuous peritoneal dialysis, often presents with turbid dialysate. This characteristic makes it frequently confused with peritonitis. Conservative treatments including bowel rest and dietary intervention with medium chain triglycerides are advised by many authors in the literature. However, this approach usually takes a long time before the lymphorrhagia are eventually resolved. Here, a case of chylous ascites that was successfully treated with subcutaneous octreotide, a somatostatin analogue, is reported. By shortening the bowel rest period, this treatment avoids the nutritional and immunological adverse effects. A series of peritoneal equilibrium tests were performed after administration of octreotide and the results showed that octreotide did not alter the peritoneal function in the short term. Therefore, subcutaneous octreotide administration is a safe and effective therapy in peritoneal dialysis patient with chylous ascites.

Original languageEnglish
Pages (from-to)344-347
Number of pages4
JournalNephrology
Volume10
Issue number4
DOIs
StatePublished - 08 2005
Externally publishedYes

Keywords

  • Chylous ascites
  • Octreotide
  • Peritoneal dialysis

Fingerprint

Dive into the research topics of 'Octreotide therapy for chylous ascites in a chronic dialysis patient'. Together they form a unique fingerprint.

Cite this